Healthcare · Active clinical trials

Active clinical trials in Germany in 2026

In 2026, Germany reported 1.2 K units active clinical trials, ranking 8 out of 197. This zero figure does not mean a lack of research; rather, many trials are conducted at university hospitals and are not captured in international registries. German pharmaceuticals, among Europe's strongest, focus on preclinical development and biotechnology, areas where the country has long excelled.

Data for 2026 · unit: units
Position

Germany world ranking

#8 / 197

Country position on the scale from last to first place for this indicator.

DE
#8
#197#1
Trend

Change over time

Change in indicator over the available period.

500
1990
1.2 K
2000
2.5 K
2010
3 K
2020
1.2 K
2025
1.2 K
2026

Values — units

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Active clinical trials in Germany — how much?
Based on 2026 data — 1.2 K units. This is rank #8 out of 197 countries.
What is Germany's rank by Active clinical trials?
Germany ranks #8 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Germany?
Over the available period the indicator changed from 500 to 1.2 K units.